SCOPUS 정보 검색 플랫폼

Volumn 10, Issue 2, 2002, Pages 425-432

ω-(Imidazol-4-yl)alkane-1-sulfonamides: a new series of potent histamine H3 receptor antagonists

(6) Tozer, Matthew J a Buck, Ildiko M a Cooke, Tracey a Kalindjian, S Barret a Pether, Michael J a Steel, Katherine I M a

a James Black Foundation (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE H3 RECEPTOR; HISTAMINE H3 RECEPTOR ANTAGONIST; OMEGA (IMIDAZOL 4 YL)ALKANE 1 SULFONAMIDE DERIVATIVE; SULFAMIDE DERIVATIVE; SULFONAMIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOASSAY; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG RECEPTOR BINDING; DRUG SPECIFICITY; DRUG SYNTHESIS; FREEZE DRYING; GUINEA PIG; ILEUM; IN VITRO STUDY; NONHUMAN; STRUCTURE ACTIVITY RELATION; TEMPERATURE;

ANIMALS; BENZYL COMPOUNDS; BIOCHEMISTRY; CEREBRAL CORTEX; DRUG EVALUATION, PRECLINICAL; GUINEA PIGS; HISTAMINE ANTAGONISTS; IMIDAZOLES; RECEPTORS, HISTAMINE H3; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0036132201 PISSN: 09680896 EISSN: None Source Type: Journal
DOI: 10.1016/S0968-0896(01)00295-4 Document Type: Article

Times cited : (12)

References (36)

1
- 0020587209
- (1983) Nature , vol.302 , pp. 832
- Arrang, J.M.¹ Garbarg, M.² Schwartz, J.C.³

2
- 0023653116
- (1987) Nature , vol.327 , pp. 117
- Arrang, J.M.¹ Garbarg, M.² Lancelot, J.C.³ Lecomte, J.M.⁴ Pollard, H.⁵ Robba, M.⁶ Schunack, W.⁷ Schwartz, J.C.⁸

3
- 0006823786
- 3 Receptor, A Target for New Drugs; Pharmacochemistry Library-Volume 30; Elsevier: Amsterdam, 1998.

4
- 0030015542
- (1996) Drugs Fut. , vol.21 , pp. 507
- Stark, H.¹ Schlicker, E.² Schunack, W.³

5
- 0031858013
- (1998) Trends Pharmacol. Sci. , vol.19 , pp. 177
- Leurs, R.¹ Blandina, P.² Tedford, C.³ Timmerman, H.⁴

6
- 0033921052
- (2000) Exp. Opin. Ther. Patents , vol.10 , pp. 1045
- Tozer, M.J.¹ Kalindjian, S.B.²

7
- 0033051582
- (1999) Mol. Pharmacol. , vol.55 , pp. 1101
- Lovenberg, T.W.¹ Roland, B.L.² Wilson, S.J.³ Jiang, X.⁴ Pyati, J.⁵ Huvar, A.⁶ Jackson, M.R.⁷ Erlander, M.G.⁸

8
- 0034689572
- (2000) NeuroReport , vol.11 , pp. 755
- Tardivel-Lacombe, J.¹ Rouleau, A.² Héron, A.³ Morisset, S.⁴ Pillot, C.⁵ Cochois, V.⁶ Schwartz, J.C.⁷ Arrang, J.M.⁸

9
- 0034047202
- (2000) J. Pharmacol. Exp. Ther. , vol.293 , pp. 771
- Lovenberg, T.W.¹ Pyati, J.² Chang, H.³ Wilson, S.J.⁴ Erlander, M.G.⁵

10
- 0033621615
- (2000) Trends Pharmacol. Sci. , vol.21 , pp. 11
- Leurs, R.¹ Hoffmann, M.² Wieland, K.³ Timmerman, H.⁴

11
- 0006816994
- (b)Anon. Exp. Opin. Ther. Pat., 2000, 10, 1607.

12
- 0000234113
- (1999) Curr. Opin. Cent. Peripher. Nerv. Syst. Invest. Drugs , vol.1 , pp. 524
- Halpern, M.T.¹

13
- 0006812656
- (b)Gliatech Inc. Press Release. May 23, 2000; (http://www.gliatech.com/news/news.cfm).

14
- 0033545582
- (1999) J. Med. Chem. , vol.42 , pp. 903
- Ali, S.M.¹ Tedford, C.E.² Gregory, R.³ Handley, M.K.⁴ Yates, S.L.⁵ Hirth, W.W.⁶ Phillips, J.G.⁷

15
- 0033918980
- (2000) J. Med. Chem. , vol.43 , pp. 2362
- Linney, I.D.¹ Buck, I.M.² Harper, E.A.³ Kalindjian, S.B.⁴ Pether, M.J.⁵ Shankley, N.P.⁶ Watt, G.F.⁷ Wright, P.T.⁸

16
- 0032412527
- (1998) Arch. Pharm , vol.331 , pp. 395
- Ganellin, C.R.¹ Leurquin, F.² Piripitsi, A.³ Arrang, J.M.⁴ Garbarg, M.⁵ Ligneau, X.⁶ Schunack, W.⁷ Schwartz, J.C.⁸

17
- 0033230996
- (1999) Bioorg. Med. Chem. Lett. , vol.9 , pp. 3103
- Tozer, M.J.¹ Buck, I.M.² Cooke, T.³ Kalindjian, S.B.⁴ McDonald, I.M.⁵ Pether, M.J.⁶ Steel, K.I.M.⁷

18
- 0006779381
- (b)James Black Foundation patent publication number WO 9729092, 1997.

19
- 0033526927
- (1999) Bioorg. Med. Chem. Lett. , vol.9 , pp. 1825
- Tozer, M.J.¹ Harper, E.A.² Kalindjian, S.B.³ Pether, M.J.⁴ Shankley, N.P.⁵ Watt, G.F.⁶

20
- 0032543954
- (1998) Bioorg. Med. Chem. Lett. , vol.8 , pp. 2157
- Wolin, R.¹ Connolly, M.² Afonso, A.³ Hey, J.A.⁴ She, H.⁵ Rivelli, M.A.⁶ Williams, S.M.⁷ West R.E., Jr.⁸

21
- 0029877782
- (1996) J. Med. Chem. , vol.39 , pp. 1157
- Stark, H.¹ Purand, K.² Ligneau, X.³ Rouleau, A.⁴ Arrang, J.M.⁵ Garbarg, M.⁶ Schwartz, J.C.⁷ Schunack, W.⁸

22
- 0006778016
- James Black Foundation patent publication number WO 9905114, 1999.

23
- 0029062626
- (1995) J. Pharm. Belg. , vol.50 , pp. 179
- Ganellin, C.R.¹ Fkyerat, A.² Hosseini, S.K.³ Khalaf, Y.S.⁴ Piripitsi, A.⁵ Tertiuk, W.⁶ Arrang, J.M.⁷ Garbarg, M.⁸ Ligneau, X.⁹ Schwartz, J.C.¹⁰

24
- 0001946519
- (1998) Synlett , pp. 186
- Tozer, M.J.¹ Woolford, A.J.A.² Linney, I.D.³

25
- 0035825791
- (2001) Org. Lett. , vol.3 , pp. 369
- Greig, I.R.¹ Tozer, M.J.² Wright, P.T.³

26
- 0032483065
- (1998) Bioorg. Med. Chem. Lett. , vol.8 , pp. 2011
- Stark, H.¹ Ligneau, X.² Arrang, J.M.³ Schwartz, J.C.⁴ Schunack, W.⁵

27
- 0000891220
- (1997) Br. J. Pharmacol. , vol.122
- Watt, G.F.¹ Hamilton, L.C.² Shankley, N.P.³ Black, J.W.⁴

28
- 0023578447
- (1987) J. Pharmacol. Exp. Ther. , vol.243 , pp. 874
- Trzeciakowski, J.P.¹

29
- 0001621225
- (1997) Br. J. Pharmacol. , vol.122
- Harper, E.A.¹ Shankley, N.P.² Black, J.W.³

30
- 4243467594
- (1997) Br. J. Pharmacol. , vol.122
- Harper, E.A.¹ Gardner, B.² Griffin, E.P.³ Shankley, N.P.⁴ Black, J.W.⁵

31
- 0032698241
- (1999) Br. J. Pharmacol. , vol.128 , pp. 751
- Harper, E.A.¹ Shankley, N.P.² Black, J.W.³

32
- 0006823788
- Low, C. M. R.; Vinter, J. G.; Kalindjian, S. B.; Pether, M. J.; Black, J. W. Abstracts P151 at the joint meeting of the British Pharmacological Society and the Société Françoise de Pharmacologie, Edinburgh, UK, 1997.

33
- 0034710721
- (2000) J. Med. Chem. , vol.43 , pp. 3335
- Sasse, A.¹ Sadek, B.² Ligneau, X.³ Elz, S.⁴ Pertz, H.H.⁵ Luger, P.⁶ Ganellin, C.R.⁷ Arrang, J.M.⁸ Schwartz, J.C.⁹ Schunack, W.¹⁰ Stark, H.¹¹

34
- 0001532220
- (1995) Br. J. Pharmacol. , vol.114
- Watt, G.F.¹ Shankley, N.P.² Black, J.W.³

35
- 0017687534
- (1977) J. Med. Chem. , vol.20 , pp. 721
- Kelley, J.L.¹ Miller, C.A.² McLean, E.W.³

36
- 84986730912
- (1992) Liebigs Ann. Chem. , pp. 317
- Sellier, C.¹ Buschauer, A.² Elz, S.³ Schunack, W.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.